Assistant Health Secretary Rachel Levine, a man who claims to be a woman, has assisted Planned Parenthood in becoming the second-largest provider of cross-sex hormones in the United States, beginning to partner with them as early as 2017. Critics argue that “transgender” surgeries and treatments are cash cows for surgeons and medical providers, because patients often require “care” for a lifetime after the first life-altering intervention.
